Amoxicillin News and Research

RSS
New study reveals oral opaganib's potent in vitro activity against Omicron

New study reveals oral opaganib's potent in vitro activity against Omicron

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Rarely-used antibiotic could be a safe and affordable treatment for neonatal sepsis

Rarely-used antibiotic could be a safe and affordable treatment for neonatal sepsis

Cessation of antibiotic prophylaxis in dentistry led to no increase in infective endocarditis

Cessation of antibiotic prophylaxis in dentistry led to no increase in infective endocarditis

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Large trial finds little effect of antibiotic amoxicillin for treating chest infections in children

Large trial finds little effect of antibiotic amoxicillin for treating chest infections in children

Early life exposure to antibiotics could alter brain development

Early life exposure to antibiotics could alter brain development

Novel technique helps evaluate the effect of potential inhibitors on antibiotic-resistant bacteria

Novel technique helps evaluate the effect of potential inhibitors on antibiotic-resistant bacteria

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Cholestenone could be a new antibacterial drug against H. pylori

Cholestenone could be a new antibacterial drug against H. pylori

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Study profiles the nose to predict immune response during COVID-19

Study profiles the nose to predict immune response during COVID-19

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Polygenic risk score can predict risk of drug-induced liver injury

Polygenic risk score can predict risk of drug-induced liver injury

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

Study: Frequent use of antimicrobial drugs impairs bacterial diversity in saliva

Study: Frequent use of antimicrobial drugs impairs bacterial diversity in saliva

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Study examines changes in prescription patterns during COVID-19 pandemic

Study examines changes in prescription patterns during COVID-19 pandemic